Beiträge

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines

Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma

Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients

Brain Tumor Immunotherapy: What have We Learned so Far?

Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model

Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?

Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells

Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies

Dendritic cell immunotherapy in uterine cancer

Wilms‘ Tumor Gene 1 (WT1)–loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial